ArticleEuropean journal of nuclear medicine and molecular imaging2026

First αvβ6-integrin targeted radioligand therapy of breast cancer using Lu-177-Therahexin.

Michael C Kreissl et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.